Stories related to Patients

How our Diagnostics business works

At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe.

Managing disease with diagnostics

Delivering life-changing information across oncology, infectious disease, cardiometabolic disease, central nervous system disease and other areas to help people get the care they need.

Pursuing cancer elimination one cancer type at a time

Curing or eliminating cancer for long seemed like a pipe dream. But that is starting to change. Eliminating cervical cancer is within reach.

Diagnostics for infectious diseases

Protecting people from pathogens requires innovative strategies, coordinated efforts, and a firm commitment to act.

Diagnostics in cardiometabolic disease

Driving early identification and supporting last-minute intervention with self-management devices as well as digital and diagnostic solutions to help improve the quality of patients’ lives.

Diagnostics in oncology

Every cancer is unique. Throughout each person’s journey, diagnostic testing helps to uncover key insights that support better outcomes.

The value of diagnostics

The quest for better solutions to healthcare’s challenges starts with and depends on diagnostics.

Diagnostics for central nervous system disease

Our efforts in advancing innovative testing strategies are helping to change the future outlook for people with degenerative diseases.

Roche Diagnostics

The quest for better solutions to healthcare’s challenges starts with and depends on diagnostics.

How One Liver is helping to stop liver disease progression

Millions of people are living with liver disease. Find out how we’re working to tackle chronic liver disease from every angle.

Liver cancer

HCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.

Decentralised clinical trials are opening new opportunities

New challenges means new solutions. Clinical research is being redefined in light of COVID-19 and the adoption of decentralised clinical trials

Staying connected, so you don’t feel disconnected

Hear from members of the multiple sclerosis community who share their experiences of how connecting with others has helped them to feel supported.

The new normal: Optimising patient care in a virtual world

This page summarises the virtualisation of care whitepaper through the presentation of success stories and healthcare professional perspectives.

Haemophilia Treatment for All - A partnership for better access

We celebrate the WFH’s Humanitarian Aid Program, and its mission of improving access to treatment in developing countries.

Roche in Haemophilia

Find out more about haemophilia A and how Roche is working closely with the community to transform haemophilia care.

Finding a new normal after breast cancer

Life changed in an instant for Nicole when she received her breast cancer diagnosis. Learn how this young mom fought the disease.

Setting personal goals for a future with multiple sclerosis

Understanding your MS can help you in setting small, achievable goals now, which can help you manage your disease, for the future.

Increasing access to healthcare

Groundbreaking advances in medical science are only meaningful when they reach the people who need them.

Patient partners

To do our best for patients, we need to work with them. Learn more about the importance of patient partnerships in shaping the future of healthcare

Pandemic-proof patient advocacy

How COVID-19 has changed the world of a patient leader When work involves advocating for diseases other than COVID-19, the pandemic presents an additional barrier to overcome.

The continuing evolution of clinical trials

Nowadays, clinical trials are highly structured and regulated, ensuring the safety of the participants, but this hasn't always been the case.

Revolutionising clinical research through digital innovation

Can smartphone apps help us solve unanswered questions in rare diseases? Roche’s Scott Schobel discusses recent innovations in Huntington’s disease research.

Spinal Muscular Atrophy (SMA)

Roche has been working in partnership with the SMA community to transform outcomes for a broad range of people living with the rare, neurological condition.

Find out what Roche is doing to #PutCancerToTheTest

Roche is raising awareness of cancer genomic testing and the latest advances in personalised healthcare. Find out how you can help #PutCancerToTheTest

Taking control of IPF: A tale of two perspectives

Rainer, who was diagnosed with idiopathic pulmonary fibrosis (IPF) after two stressful years of uncertainty, tells his story on living with IPF alongside expert advice from his doctor.

Pregnancy after preeclampsia

Is it safe to have another baby?

Let’s talk fertility

Women and their bodies may have very different ideas about the right time to have a baby.

Women’s health at every stage of life

Every woman’s journey through life is her own, yet all face similar choices and challenges. Health is critical at every stage of this journey.

The many faces of breast cancer

Each women is unique. But breast cancer doesn’t care. It can happen to anyone. And when it does happen, each woman’s breast cancer is as individual as she is.

Cancer genomic testing – Jamal Tamer’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Jamal Tamer about the real-world impact it can have.

Cancer genomic testing – Debbie Rhea’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient Debbie Rhea about the real-world impact it can have.

For a life beyond NMOSD

Neuromyelitis optica spectrum disorder (NMOSD) can severely affect a person’s quality of life. Find out how the right support can bring stability to their life.

Can wearable technology change the future of neuroscience research?

Scientists are finding new, innovative ways to collect clinical trial data in real-time that will allow regulators to make more accurate, informed decisions

ForPatients

Developed in partnership with patients, ForPatients aims to support patients on their journey.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Roche's innovation and collaboration in ophthalmology

We value the importance of collaboration and innovation to drive change for people living with vision loss and their loved ones

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Learning about the science behind NMOSD

Understanding neuromyelitis optica spectrum disorder (NMOSD) and the role of interleukin-6 in the inflammation that occurs in people with NMOSD

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Our mission is rooted in our formula: follow the science to preserve what makes people who they are.

For cancer patients, personalised care matters more than ever

Mobile blood draw programs bring comprehensive genetic profiling and personalised care to cancer patients – the hidden victims of the pandemic

Blood ties: in it together

Collaborating with the haematology community can help accelerate treatment advances for people affected by blood disorders, a complex area of medicine.

Voices for health podcast

Bringing together voices of experts, policy makers and researchers to explore and determine ways to solve some of society’s most pressing health questions.

An evolution in strategies for cervical cancer prevention

Advanced screening and diagnostic tests are key to improving disease prevention strategies.

Nurses make the difference in Diabetes Management

Nurses make a life-changing difference creating a more accessible, high quality and personalised environment for people with diabetes in need.

A woman's right to know: HPV and cervical cancer

The HPV test came back positive – what now? Should women be worried? What should they do next?

Cancer care can’t wait

Lung cancer in the era of COVID-19

Finding cancer’s fingerprint

How comprehensive genomic profiling – through tissue and liquid-based approaches – is driving truly personalised cancer care.

Sharing experiences of life with SMA My Way

We have so much to learn from each other about tackling the everyday challenges of spinal muscular atrophy. Find out how we can through SMA My Way.

Europe has long stood strong as a leader in healthcare

Europe has long stood strong as a leader in healthcare. It is the home of great scientists, physicians and academic institutions, a leader in the provision of universal healthcare.

Rebuilding Europe’s leadership in biomedical innovation

About thirty years ago Europe had a leading, vibrant healthcare sector, but for the past several years, the region has been falling behind the US and a strongly growing and committed China.

Reimagining breast cancer

Each woman has her own story of cancer, her own shade of pink. That’s why we’re exploring whether breast cancer can be a single shade, when it’s not a single disease.

The EU Health Data Space race A bold vision for healthcare in Europe

The COVID-19 pandemic revealed the limitations of the current EU health data system; for Roche, a shared EU health data program is the solution.

Behind every patient: Healthcare heroes in Africa

Celebrating the health care professionals across Africa providing safe, quality breast cancer care and supporting patients during the COVID-19 pandemic.

It takes the power of partnership

With a shared dedication to bring innovative treatments to SMA patients, the SMA Foundation, PTC Therapeutics and Roche show the power of collaboration.

Uncovering stories of progression from the MS community

The MS community shares what they want others to know about the often invisible symptoms of MS, as well as their journey to managing its hidden impact.

Explore the role of a specialist MS nurse

Learn how specialist MS nurse Anna Cunningham, helps people with MS manage their condition

Roche at ESMO 2020

Elena Bernedo Arzac, Head of Oncology, GPS at Roche Pharmaceuticals: Accelerating innovation with collaboration throughout the pandemic.

Risk of relapse

Neuromyelitis optica spectrum disorder (NMOSD) causes relapses that can cause neurological disability. Hear what it is like to live with the risk of relapse.

Living with NMOSD: Advice from a working mother

Ana has neuromyelitis optica spectrum disorder (NMOSD) but has learnt to understand her condition and remain positive. She shares her story here.

Finding hope in difficult times

Michelle’s diagnosis with NMOSD initially devastated her, but she refuses to let it prevent her from living her life. She shares her story here.

“We need to future-proof our systems”

Padraic Ward, Head of Pharma International at Roche, talks about his vision for healthcare and the opportunities and challenges for Europe.

Taking it off the ground

This clinical trial had to start quickly to test if an old Roche drug helped serious COVID-19 patients. A Roche veteran is coordinating these efforts.

Neuromyelitis optica spectrum disorder (NMOSD)

NMOSD is a rare and lifelong autoimmune disease of the central nervous system

What is IBD?

IBD is a group of complex, chronic conditions, characterised by prolonged inflammation of the gastrointestinal tract, which can have a long-term impact on a patient's quality of life.

Separating fact from fiction: connecting the MS community

Learn how the MS community can stay connected not only to each other, but also to reliable and helpful resources as we journey through these unprecedented times.

Do you know the difference between the flu and a cold?

Influenza or ‘flu” is a viral infection that causes characteristic symptoms, which can help you identify it early and seek medical advice.

A rare diagnosis

Chelsey spent ten years incorrectly diagnosed with MS before she was eventually diagnosed with a rare disease, NMOSD. She shares her story here.

Discussing multiple sclerosis through storytelling

Hear from Annarita and her family about how she used storytelling to explain the impact of the progressive nature of multiple sclerosis.

Tip of the iceberg: the hidden impact of Alzheimer’s disease

Caring for people with Alzheimer’s disease has a huge economic and emotional impact. Learn about the intangible costs and Freeha’s experience with her father.

The hidden impact of flu: Allison’s story

Allison Miller was living a normal life when complications arising from the flu changed everything.

Reimagining breast cancer with a new palette of pink

Each woman has her own story of cancer, her own shade of pink. We explore the stories of different women who share their unique experience with breast cancer.

Haematology: It’s in our blood

Learn more about this complex and challenging area of medicine, and how Roche is redefining treatment for people with diseases of the blood.

Every Cancer Is Unique. Let’s Treat It That Way.

Every cancer is unique. Discover how genomic testing can reveal mutations in a cancer tumour that can guide personalised treatment decisions.

Hunting for solutions

Find out how Roche is harnessing the latest technology to treat Huntington’s disease.

Lung Cancer Awareness Month: An evolution

By continuing to challenge the stigma associated with lung cancer, we hope to drive improved outcomes for patients this November and beyond.

Building bridges to improve the cancer patient journey

The role of an oncology nurse navigator requires a unique combination of skills, knowledge and compassion.

The future is patient-centric and data-driven

Tim M. Jaeger talks about the future of healthcare, the power of knowing and why human interaction will remain indispensable in the age of AI.

Shaping the future of cancer care

Combining science, partnerships and analytics in the fight against cancer.

Global Access Program

According to the World Health Organization (WHO), there were 35 million people living with HIV around the world in 2012. That same year 2.5 million people became newly infected with HIV worldwide.

When patients are fully in control of their healthcare data

Partnering directly with patients opens up exciting ways to transparently share data and gain access to some of the richest datasets available to researchers.

What patients in clinical trials should know about their data

Patients can be at risk of sharing too much, especially in Rare diseases. How can patient advocates support innovation but also defend patient privacy?

Personalised healthcare and the complexity of data sharing

Mark Lee & Tim Jaeger discuss the shifting the paradigm of transparency and patient privacy when it comes to data

Just the other day, I realised I could open the fridge again

Conversations with people with SMA and their families

Healthy liver, healthy lives

The liver is your body’s chemical processing plant, a powerhouse crucial to remove toxins; but liver cancer is on the rise. Learn what we can do to change this.

Roche results for half-year 2019

When everyday counts, data makes a meaningful difference for patients

Improving the supply chain

Gaps in the supply chain resulted in cost mark-ups putting modern cancer therapies out of reach for patients in sub-Saharan Africa.

Our philanthropic journey

Over 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.

A journey towards mutual understanding in IBD

A look at the importance of patient-physician communication in ulcerative colitis and Crohn’s disease, and how we are developing digital tools to help address this.

Piecing together the puzzle of IBD

Read how we are approaching personalised healthcare in IBD to support individualised care for people living with ulcerative colitis and Crohn’s disease.

Inflammatory bowel diseases

We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.

Roche's personalised approach in IBD

Compare today's approach in IBD with the ideal future

Master the art of detection for skin cancer

Take a tour of our virtual gallery and learn to master the art of detection for skin cancer. It could help you save lives.

Changing the colorectal cancer story

Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.

Life with NMOSD: Staying who you are with a rare disease

“Do not take life for granted. Take every moment in.”

Fighting counterfeits to protect patients

For patients whose lives depend on prescription medicines, the consequences of counterfeiting are dramatic.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Small cell, big difference

Understanding what makes small cell lung cancer unique and what is being done to improve the lives of people with small cell lung cancer.

Exposing the impact of progression in multiple sclerosis

Pieter shares his experiences of progression in MS, and how virtual reality can help facilitate discussions about progression within the MS community.

The role of diagnostics in fertility and pregnancy

Learn more about advanced screening and diagnostics tests and their role in preconception and pregnancy.

Rare diseases are not rare

Find out what makes a rare disease rare and who is affected.

Elevating the patient voice in Huntington’s disease

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

Staying active despite progression: Anat’s Story

Explore Anat’s powerful message of staying active despite her progression in multiple sclerosis.

About the importance of disease awareness

Four key factors need to be in place to successfully treat a patient, the first factor is disease awareness.

Lung cancer and me

Every person affected by lung cancer has their own unique story to tell.

Would you share your health data?

Most patients are willing to share their data to contribute to medical progress, but they want transparency.

The city cancer challenge

An initiative that aims to build a collective movement of cities across the globe to deliver better solutions on sustainable cancer treatment for all.

Stolen memories

Diagnostic certainty contributes to the search for effective treatment

Confronting IPF together: Alberto and Maria’s story

Find out why Alberto now celebrates two birthdays – and why he and his wife Maria don’t take a single breath for granted.

Finding her way

Born with hepatitis, Adeline chose to face her diagnosis and define her future.

Addressing the lack of cancer care in Pakistan

The patient as partner

Empowered patients are redefining the healthcare environment on their own terms.

Our access to healthcare initiatives

Explore some of our access projects from around the globe.

Increasing access to healthcare is a global challenge

Finding sustainable solutions to the barriers to healthcare can only be achieved through collaboration.

A mosaic of life after cancer

Stories of survival not only provide hope to cancer patients, but they also remind oncologists why they work so hard to find new treatments.

Improving access to hepatitis treatment in Egypt

Comprehensive access to cancer treatment in Dubai

A platform for supporting cancer patients in India

India does not have a centralised healthcare funding body and access to medicines is not universal.

Improving cancer care in Bosnia and Herzegovina

Relapsing multiple sclerosis: Unravelling the maze

Explore how the patient pathway for people living with relapsing MS has changed over the past 20 years.

Progress in haemophilia: a personal perspective

The haemophilia community is united and strong. Find out more about the haemophilia community and progress being made in the field from Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.

A pathway to hope for cancer patients

Barriers to accessing healthcare in Kenya include poor diagnosis and inadequate funding. Public-private partnerships aim for innovative and sustainable solutions.

Sustainability at Roche: Our impact

Engaging with stakeholders is crucial to create sustainable value. Stakeholder engagement enables us to jointly develop solutions.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Highlights Annual Report 2017

Read the incredible stories behind the numbers.

Bringing patient support to a rare disease

Learn how we are breaking down barriers that prevent patients from joining clinical trials for spinal muscular atrophy.

Making HIV testing accessible

The Global Access Programme makes HIV viral load tests and the early detection of infections in infants possible in countries that are most affected by the disease.

Living with MS: My Story

Felix, who lives with relapsing MS and Craig, who lives with primary progressive MS, talk about the impact of the disease on their daily lives.

About the importance of funding

Four key factors need to be in place to successfully treat a patient, with funding being the most controversial one.

About the importance of healthcare capacity

Healthcare capacity is one of four key factors that need to be in place to successfully treat a patient.

About the importance of diagnosis

Four key factors need to be in place to successfully treat a patient, with diagnosis being one of them.

Our approach to increase access to healthcare

Access to healthcare is a complex challenge. Four key factors need to be in place to improve access to quality healthcare.

Partnership to improve cancer care in Sudan

The partnership builds a cornerstone to fight breast and blood cancers by providing people access to innovative biotech medicines and diagnostic solutions.

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Digital solutions supporting rheumatoid arthritis community

It has become natural for people to seek information or advice about their health online. Learn about three solutions we developed for the European RA community.

Every person is unique. So is every cancer.

Advances in genomics are helping physicians to understand patients’ unique cancer types and to identify whether targeted therapy options are available for them.

Ann’s story - what it feels like to live with IPF

More than three years after learning she has IPF, Ann still refuses to allow the disease to overshadow her life. Read about how she learned to live with IPF.

Mesothelioma: What could possibly link this rare cancer to the ill-fated Titanic?

What could possibly link this rare cancer to the ill-fated Titanic?

A life-changing wake-up call

How cancer gave one woman strength and clarity of purpose.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

Working through MS

The unpredictability of MS can greatly affect employment and career opportunities. Learn about the impact of MS on work life.

After years of uncertainty - a difficult diagnosis

Ann has idiopathic pulmonary fibrosis, a relentless condition which causes scarring of the lungs. This is the story of her search for answers, from initial symptoms to diagnosis.

Forms of multiple sclerosis: What are the similarities and differences?

The underlying biology of multiple sclerosis is similar for everyone, but its course and symptoms vary from person to person. Explore the similarities and differences between two forms of MS.

Lymphoma: Know the facts

Lymphoma is one of the most prevalent forms of blood cancer. Click on our interactive flashcards to find out some key facts on lymphoma we all should know.

Heart failure: the role of biomarkers in disease management

Heart failure can have a great impact on people’s live. Biomarkers can support physicians to make informed decisions as to the best course of care to patients.

Fighting viral hepatitis

Despite the burden it places on communities across the world, hepatitis appears to have been largely ignored as a public health concern

A little-known virus that can cause big problems

Most people can spend their entire lives not knowing they’ve been infected with CMV. But for transplant patients, this quiet invader can be life-threatening

Disease Progression Slideshow

MS disease progression is complicated and not always apparent. Learn what happens to the body in MS and how progression can be measured.

Improving outcomes for people with multiple sclerosis

The London School of Economics “International MultiPlE Sclerosis Study” explores the need for policy change and better outcomes for people with MS.

Life with MS: My inspiration

French visual artist, Dorothy Shoes, talks about her life and how MS inspires her work.

Facing unpredictability head on

MS patient advocate Shana, and her partner Leo, explain what it’s like to live with a disease that means no two days are the same.

Be a Melanoma Hero

Meet our Melanoma Heroes. They support those who have melanoma and take steps to prevent the disease, support their loved ones or lead the way to a cure.

Bladder cancer: the symptoms you shouldn’t ignore

One patient shares his experience being diagnosed with a disease he knew nothing about.

Protecting against progression

Dr. Traboulsee, University of British Columbia in Vancouver, discusses the importance of brain health and early treatment for people with multiple sclerosis.

What is multiple sclerosis?

MS is usually thought of as a single disease, but its course and symptoms vary from person to person.

Facts about bladder cancer

Bladder cancer is one of the top ten most common cancers in the world.

Lung cancer

Approximately 1.8 million people develop lung cancer every year. Can new diagnostic tools deliver earlier diagnosis and smarter treatment choices?

Tackling cancer in Kenya

Our partnership with the Beth Mugo Cancer Foundation is helping cancer patients in Kenya.

Our purpose

Who we are, what we do, and why we come to work each day.

Access Accelerated: improving access to medicines for NCDs

Working together for a future where no one dies prematurely from a treatable preventable disease.

No woman needs to die from cervical cancer

Despite being highly preventable through screening,treatment and vaccination, cervical cancer remains one of the most common and deadly women’s cancer.

Buttons - daily enemies for people with rheumatoid arthritis

New clothing collection designed to overcoming issues that people with RA face when getting dressed.

Rheumatoid arthritis through the lens of an Slovenian artist

A photographer captures what it means to live with the consequences of rheumatoid arthritis.

8 things people with rheumatoid arthritis want you to know

Rheumatoid arthritis really affects people living with it. Here’s what they would like you to know about the disease.

Providing a helping hand for people with rheumatoid arthritis

A collaboration with the Brazilian patient advocacy group helps to improve the quality of life of people living with RA.

Life with rheumatoid arthritis through pictures and words

The three artists captured what living with the disease means to people with rheumatoid arthritis.

Idiopathic pulmonary fibrosis: Uniting European patient voices

For people suffering from IPF, the work of patient associations is crucial as they highlight the urgency for new research and raises awareness of the disease.

The complexities of lymphoma: The importance of subtypes

With more than 90 subtypes, non-Hodgkin lymphoma is a complex group of diseases. Read this article to learn more.

Japan: When lipstick means independence

As rheumatoid arthritis (RA) progresses, joints stiffen and eventually become so badly affected that people with RA become more dependent on others for help to complete daily tasks.

Roche signs agreement with Kenya to improve breast cancer launches

First Lady Margaret Kenyatta, Kenya Ministry of Health and Roche launched key activities that will facilitate access to improved care for patients with breast cancer in Kenya today.

Advancing haemophilia management

Roche is developing novel approaches to hopefully advance the management of haemophilia A.

What drives Liam Galvin, Secretary of EU-IPFF?

Over 200,000 patients across Europe and the United States have idiopathic pulmonary fibrosis (IPF), an incurable lung disease more deadly than most cancers.

Innovative pricing solutions

We are putting into practice innovative pricing solutions to broaden access to our medicines.

A vision for the future

Find out what being part of the community means to the World Federation of Hemophilia and why World Hemophilia Day is such a critical event.

Working with patient organisations

Patient organisations are increasingly important partners for Roche. We share an interest in helping patients understand and manage their disease.

Research and clinical trials

Find out how we determine whether new drugs, diagnostics or procedures in the laboratory are both safe and effective when used to diagnose or treat people.

Getting medicines to people with breast cancer sooner

Find out how we are pushing the boundaries of science and creating opportunities to bring medicines to people with breast cancer sooner.

Things you may not know about skin cancer

From the origins of the word melanoma to the worrying statistics today, these are some of the interesting facts about skin cancer everyone one needs to know.

Testing newborns for HIV

Newborns at risk of HIV need to be tested quickly. Discover why every day counts and how access to HIV diagnostics are making a difference.

Helping establish private health insurance in China

Collaboration between Roche and major insurance companies to develop affordable cancer polices which provide appropriate cancer care